Author:
Cerdá Jorge,Tolwani Ashita,Shah Shamik,Ronco Claudio
Publisher
Springer Berlin Heidelberg
Reference201 articles.
1. Apsner, R., Schwarzenhofer, M., Derfler, K., et al.: Impairment of citrate metabolism in acute hepatic failure. Wien Klin Wochenschr 109(4), 123–127 (1997)
2. Arepally, G.M., Ortel, T.L.: Clinical practice. Heparin-induced thrombocytopenia. New England Journal of Medicine 355(8), 809–817 (2006)
3. Baker, B.A., Adelman, M.D., Smith, P.A., Osborn, J.C.: Inability of the activated partial thromboplastin time to predict heparin levels. Time to reassess guidelines for heparin assays. Arch. Intern. Med. 157(21), 2475–2479 (1997)
4. Bakker, A.J., Boerma, E.C., Keidel, H., et al.: Detection of citrate over-dose in critically ill patients on citrate-anticoagulated venovenous haemofiltration: use of ionised and total/ionised calcium. Clin. Chem. Lab. Med. 44(8), 962–966 (2006)
5. Bagshaw, S.M., Laupland, K.B., Boiteau, P.J., et al.: Is regional citrate superior to systemic heparin anticoagulation for continuous renal replacement therapy? A prospective observational study in an adult regional critical care system. J. Crit. Care 20(2), 155–161 (2005)